Mr. Roy, we have infectious disease experts writing to our committee and telling us that Bill C-275 in its current form does not address existing biosecurity disease risks. From the industry point of view, how do you respond to experts who are asking our committee to amend this bill or not pass it in its current form? I just want your response to experts in the field.
On October 5th, 2023. See this statement in context.